Literature DB >> 6794081

Naloxone changes self-ratings but not performance in normal subjects.

S E File, T Silverstone.   

Abstract

The effects of single intravenous doses of naloxone (0.8 and 1.6 mg) in a variety of performance tasks and on subjective ratings of mood and bodily symptoms were investigated in 12 student volunteers. Naloxone was without effect on any of the performance measures. However, 5 min after naloxone (1.6 mg) the subjects felt significantly more troubled, mentally slow, incompetent, withdrawn and physically tired, and less irritable. These effects appeared to be dose-related since 0.8 mg produced similar, but not statistically significant changes. Sixty-five minutes after the higher dose subjects felt significantly more muzzy and incompetent; in contrast to the effects at 5 min they now felt significantly more irritable. These results are difficult to explain solely in terms of opiate receptor blockade.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6794081     DOI: 10.1007/BF00432746

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  8 in total

Review 1.  On the specificity of naloxone as an opiate antagonist.

Authors:  J Sawynok; C Pinsky; F S LaBella
Journal:  Life Sci       Date:  1979-11-05       Impact factor: 5.037

2.  Naloxone treatment of opiate dependence. A progress report.

Authors:  A Zaks; T Jones; M Fink; A M Freedman
Journal:  JAMA       Date:  1971-03-29       Impact factor: 56.272

3.  Electroencephalographic and other effects of naloxone in normal men.

Authors:  J Volavka; B James; D Reker; V Pollock; D Cho
Journal:  Life Sci       Date:  1979-10-01       Impact factor: 5.037

4.  Effects of naloxone on experimentally induced ischemic pain and on mood in human subjects.

Authors:  P Grevert; A Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

5.  Naloxone-induced behavioral and physiological effects in normal and manic subjects.

Authors:  L L Judd; D S Janowsky; D S Segal; L Y Huey
Journal:  Arch Gen Psychiatry       Date:  1980-05

6.  The human pharmacology and abuse potential of N-allylnoroxymorphone (naloxone).

Authors:  D R Jasinski; W R Martin; C A Haertzen
Journal:  J Pharmacol Exp Ther       Date:  1967-08       Impact factor: 4.030

7.  Impaired performance and sedation after a single dose of lorazepam.

Authors:  S E File; A J Bond
Journal:  Psychopharmacology (Berl)       Date:  1979       Impact factor: 4.530

8.  Naloxone reduces social and exploratory activity in the rat.

Authors:  S E File
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

  8 in total
  2 in total

1.  Effects of naloxone on diurnal rhythms in mood and endocrine function: a dose-response study in man.

Authors:  A F Martin del Campo; J H Dowson; J Herbert; E S Paykel
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

2.  Naloxone's effect on cognitive functioning in drug-free and diazepam-treated normal humans.

Authors:  O M Wolkowitz; J R Tinklenberg
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.